Prevention and treatment of kidney transplantation rejection by means of innovative therapeutic apheresis.
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2014
At a glance
- Drugs Rituximab (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 24 Mar 2012 Last checked against European Clinical Trials Database record.
- 28 Jul 2011 New trial record